Spurious Drugs Case: Baddi Firm Owner Fails To Join Probe

Solan : Mukesh Saini, proprietor of Magnatek Enterprises, a pharmaceutical firm allegedly involved in the production of spurious drugs, failed to join the investigation at Baddi today.

The authorities sealed the unit on July 16 after seizing spurious drugs manufactured in violation of the Drugs and Cosmetics Act. The officials will inspect the premises in his presence.

CCTV footage obtained by drug officials showed him leaving the firm premises in a hurry around 8 pm on Sunday soon after a consignment was seized at the godown of a transport company.

He had reportedly received a call from the staff of the transport company about the seizure following which few other employees also made a hasty retreat on a bike while few lower-rung employees were left working in the unit.

Drugs Controller Navneet Marwaha said proprietor of Magnatek Enterprises Mukesh Saini failed to join the probe over the past two days. He has been granted the last opportunity tomorrow following which appropriate action would be taken against him.

With water-logging plaguing Delhi, the drug authorities are yet to verify whether a wholesale chemist in central Delhi had received any stock of spurious drugs manufactured at the Magnatek unit in the past.

Such a stock would be withdrawn from the market. The officials were verifying the other drug consignments sent by the firm to Chandigarh and other places.

It has been observed that wholesale traders from other states have direct links with the manufacturers at Baddi.

Related Posts

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

The ministry of health and family welfare has declared the Pharmacy Council of India’s (PCI) recently notified regulation on the pharmacist recruitment, promotion and services as ultra vires and does…

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

NAIROBI/GENEVA— In an alarming development that underscores the accelerating global crisis of antimicrobial resistance, researchers have confirmed the detection of a rare, pan-drug resistant strain of the high-priority fungal pathogen…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications